Cited by 168Pancreatic and Hepatic Oncology ResearchMetabolism, Diabetes, and CancerCancer, Lipids, and Metabolism

Prevalence of Diabetes Mellitus in Pancreatic Cancer Compared to Common Cancers

Open access
Aggarwal, Gaurav, Kamada, Pratima, Chari, Suresh T.·2013·Pancreas

Abstract

OBJECTIVES: In pancreatic cancer (PaC), the prevalence of diabetes mellitus (DM), especially new-onset DM (≤36 months of PaC diagnosis), is high. To determine if this observation is unique to PaC, we compared the prevalence and characteristics of DM in lung, breast, prostate, and colorectal cancers with PaC and noncancer controls. METHODS: We retrospectively reviewed the medical records of 500 consecutive patients with cancer (100 each with lung, breast, prostate, and colorectal cancers and PaC) and 100 noncancer controls. RESULTS: Patients with PaC (mean age ± SD, 71.6 ± 9.4 years; 53% men) had a significantly (P < 0.0001) higher prevalence of DM (68%) compared to age-matched patients with lung (mean age ± SD, 71.6 ± 9.4 years; 59% men; and 19.6% DM), breast (mean age ± SD, 71.6 ± 9.6 years; 100% women; and 19.4% DM), prostate (mean age ± SD, 71.3 ± 9.4 years; 100% men; and 14.8% DM), and colorectal cancer (mean age ± SD, 71.6 ± 9.5 years; 56% men; and 20.7% DM), and noncancer controls (mean age ± SD, 70.7 ± 9.2 years; 57% men; and 23.5% DM). Among the patients with PaC, 40% developed DM in the 36 months preceding the diagnosis of PaC compared with 3.3% to 5.7% in the other groups (P < 0.0001). CONCLUSIONS: Whereas the prevalence of DM in PaC is very high, DM prevalence in other common cancers is no different from that in noncancer controls. In particular, new-onset DM is a phenomenon that is unique to PaC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mpa.0b013e3182592c96

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Prevalence of diabetes among patients diagnosed with PDAC is remarkably higher than for any other solid tumor.

    “The prevalence of diabetes among patients diagnosed with PDAC is remarkably higher than for any other solid tumor,211”

    From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [211]

    The Results (Prevalence of Diabetes Mellitus; page not provided) report diabetes in 68% of pancreatic cancer patients, significantly higher than in patients with lung, breast, prostate, or colorectal cancer. The study compared only those four other cancers, so it does not establish the claim for any other solid tumor. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [3]Altekruse SF Kosary CL Krapcho M Accessed on June 1, 2011 SEER Cancer Statistics Review, 1976-2007 2010 National Cancer Institute Bethesda, MD based on November 2009 SEER data submission, posted to the SEER Web site Available at: http://www.cancer.org/cancer/cancerbasics/cancer-prevalence

Cited by

Sorted by citations

Authors
Aggarwal, G., Kamada, P., & Chari, S. T.
Affiliations
  • Mayo Clinic (US)
  • University Medical Center Brackenridge (US)
Corresponding author
  • Aggarwal, Gaurav
  • Chari, Suresh T.
Venue
Pancreas
Published
2013-03
Volume
42
Issue
2
Pages
198-201
ISSN
0885-3177 (ISSN-L)
OpenAlex
W2045036543
Cited by
167
References
21
Citations by year
2026: 11 · 2025: 16 · 2024: 7 · 2023: 11 · 2022: 14 · 2021: 23 · 2020: 19 · 2019: 17 · 2018: 10 · 2017: 10 · 2016: 9 · 2015: 4 · 2014: 7 · 2013: 9
FWCI
3.32
Type
journal article
Language
en
Open access
Locations
  • Pancreas (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (P50CA102701, R01CA100685)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
diabetes mellitus, pancreatic cancer, new-onset diabetes, cancer-associated diabetes, lung cancer, breast cancer, prostate cancer, colorectal cancer, diabetes prevalence, cancer patients
MeSH terms
Aged, Aged, 80 and over, Blood Glucose, Breast Neoplasms, Diabetes Mellitus, Female, Humans, Lung Neoplasms, Male, Middle Aged, Minnesota, Pancreatic Neoplasms, Prostatic Neoplasms, Retrospective Studies, Risk Factors, Time Factors, Colorectal Neoplasms, Biomarkers, Prevalence, Chi-Square Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review